A Study to Develop an EEG Diagnostic for Alzheimer’s Disease

Overview

About this study

This study aims to obtain EEG data on individuals at all stages of AD from preclinical through severe dementia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Unimpaired APOE e4/4 homozygotes age 65-75 and APOE e3/4 heterozygotes age 75-85 for the preclinical AD subset and age, sex, and education matched APOE e4 noncarriers for the unaffected controls. 
  • Biomarker confirmation for preclinical diagnosis will be utilized to the extent possible (a subset of 130 members of our cohort have undergone amyloid-PET resulting in approximately 45 who are amyloid positive).

Exclusion Criteria:

  • Previous stroke.
  • Severe head injury.
  • Craniotomy.
  • Any other potentially confounding neurologic illness (typically anything that causes structural brain damage). 
  • Psychoactive medication use will not be an absolute exclusionary criterion in patients with moderate to severe dementia but patients who are relatively drug-free will be prioritized to the extent they are available within the study period. 
  • Psychoactive drug use will be exclusionary in the prospectively obtained clinical patients.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Richard Caselli, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Deborah Brostrom B.S.

(800) 664-4542

Brostrom.Deborah@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20519774

Mayo Clinic Footer